Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Hydrocortisone Panpharma |
Active Ingredient: |
Hydrocortisone hydrogen succinate 127.6mg equivalent to hydrocortisone sodium succinate 133.7mg and 100mg hydrocortisone |
Dosage Form: | Powder for injection |
New Zealand Sponsor: | Multichem NZ Limited |
Manufacturer: | Panpharma-Beignon, Beignon, France |
Product: | Metaraminol Juno (2.5mg/5mL) |
Active Ingredient: |
Metaraminol tartrate 0.949mg/mL equivalent to metaraminol 0.50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Juno Pharmaceuticals NZ Limited |
Manufacturer: | Laboratoire Aguettant SA, Lyon, France |
Product: | Metaraminol Juno (5mg/10mL) |
Active Ingredient: |
Metaraminol tartrate 0.949mg/mL equivalent to metaraminol 0.50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Juno Pharmaceuticals NZ Limited |
Manufacturer: | Laboratoire Aguettant SA, Lyon, France |
Dated this 20th day of April 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).